Affinity Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$427K Buy
4,838
+869
+22% +$78.7K 0.05% 128
2026
Q2
$371K Hold
3,969
– – 0.05% 129
2026
Q1
$338K Buy
3,969
+1
+0% +$89 0.05% 125
2025
Q4
$314K Buy
+3,968
New +$311K 0.04% 128
2025
Q2
– Sell
-2,915
Closed -$274K – 161
2025
Q1
$274K Buy
2,915
+74
+3% +$6.63K 0.05% 125
2024
Q4
$248K Hold
2,841
– – 0.05% 138
2024
Q3
$295K Buy
2,841
+1
+0% +$102 0.06% 121
2024
Q2
$276K Sell
2,840
-465
-14% -$42.9K 0.06% 123
2024
Q1
$298K Hold
3,305
– – 0.07% 119
2023
Q4
$263K Sell
3,305
-6
-0.2% -$451 0.06% 117
2023
Q3
$235K Hold
3,311
– – 0.06% 115
2023
Q2
$255K Hold
3,311
– – 0.07% 106
2023
Q1
$249K Hold
3,311
– – 0.08% 106
2022
Q4
$261K Buy
3,311
+1
+0% +$75 0.09% 91
2022
Q3
$233K Hold
3,310
– – 0.08% 92
2022
Q2
$265K Sell
3,310
-13
-0.4% -$1.02K 0.09% 90
2022
Q1
$252K Buy
3,323
+7
+0.2% +$554 0.08% 102
2021
Q4
$283K Buy
3,316
+24
+0.7% +$1.87K 0.09% 100
2021
Q3
$249K Sell
3,292
-358
-10% -$28.4K 0.08% 105
2021
Q2
$297K Hold
3,650
– – 0.1% 93
2021
Q1
$288K Sell
3,650
-118
-3% -$9.25K 0.11% 89
2020
Q4
$322K Hold
3,768
– – 0.13% 77
2020
Q3
$291K Buy
3,768
+12
+0.3% +$915 0.16% 76
2020
Q2
$275K Hold
3,756
– – 0.18% 72
2020
Q1
$276K Sell
3,756
-41
-1% -$2.89K 0.2% 76
2019
Q4
$261K Buy
+3,797
New +$259K 0.17% 91

Other funds holding CL

Affinity Capital Advisors's CL Position: Q3 2026 in Review

Affinity Capital Advisors increased its Colgate-Palmolive (CL) stake by 22% in Q3 2026, buying an estimated $78.7K and bringing the position to 4,838 shares worth $427K. The position accounts for 0.05% of the portfolio, ranked #128.

Affinity Capital Advisors first reported a position in CL in Q4 2019 and has held it in 26 quarters since. 432 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Affinity Capital Advisors held 4,838 shares of Colgate-Palmolive worth $427K as of Q3 2026.
  • Affinity Capital Advisors bought 869 Colgate-Palmolive shares in Q3 2026, an estimated $78.7K.
  • Colgate-Palmolive made up 0.05% of Affinity Capital Advisors's portfolio in Q3 2026, its #128 holding.
  • Affinity Capital Advisors first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 26 quarters since.
  • 432 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Affinity Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.